Breaking News

Accupac Adds Manufacturing Plant

October 4, 2012

Expands capacity and capabilities

Accupac is doubling capacity and expanding capabilities with a 221,000-sq.-ft. facility in Lakewood, NJ. The facility has more than 25 years of liquid contract manufacturing experience and a superior regulatory track record, according to the company. Accupac will expand its manufacturing offering to include production of ingestibles, large-scale soap and body washes, and striped toothpaste. The facility will create as many as 300 new jobs when fully staffed, according to Mark Hallett, general manager of Accupac Lakewood.
 
“Focus on strategic growth in our business over the past three years has uniquely positioned us to offer the best solutions to the liquid contract manufacturing industry,” said Mark Hinkel, vice president of sales and marketing. “This expansion allows us to offer more flexibility and capabilities to our clients. And we will continue to provide the best customer service out there.”
 
The Lakewood facility was sublet from DPT Labs. DPT has consolidated its non-sterile liquid business into its San Antonio operations and has retained its emerging specialty sterile products business in Lakewood.

Related Packaging:

Related Contract Manufacturing:

Related Compliance:

blog comments powered by Disqus
  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market

  • Flexible Manufacturing Strategies

    Kristin Brooks, Contract Pharma||April 4, 2016
    Michael Lehmann of Patheon discusses solutions for pharmaceutical forecasting errors

  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.